Optimal Planning Target Volume Margins for Elective Pelvic Lymphatic Radiotherapy in High-Risk Prostate Cancer Patients

Table 1

Patient characteristics.

Patient number	Age (years)	T stage	Gleason Score	Presenting PSA ng/mL
1	55	T2c	3+3=6	112
2	76	T1c	3+4=7	25.8
3	76	T1c	4+4=8	10.6
4	72	T2a	4+3=7	15.4
5	71	T2b	3+3=6	27.9
6	67	T1c	3+3=6	20.1
Mean	71.5			22.95